Leaflet FRAXIPARINE 3800UI AFXa/0.4ml 3800 ui AFXa / 0.4ml solution for injection

Indicated for: prevention and treatment of thromboembolism

Route of administration: injectable

Substance: nadroparin (anticoagulant)

ATC: B01AB06 (Blood and blood forming organs | Antithrombotic agents | Heparin group)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Nadroparin is a low molecular weight heparin anticoagulant used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting factor Xa, preventing the formation of blood clots.

The medication is administered via subcutaneous injection, usually once or twice daily, with the dose adjusted based on the patient's weight and therapeutic indication. Common side effects include bleeding, bruising at the injection site, and thrombocytopenia.

Nadroparin is contraindicated in patients with active bleeding, heparin-induced thrombocytopenia, or hypersensitivity to the active substance. Its use also requires careful monitoring to prevent hemorrhagic complications.

This medication is an effective option for the prevention and treatment of thromboembolic complications, helping to reduce the risk of severe cardiovascular events.

FRAXIPARINE 3800UI AFXa/0.4ml 3800 ui AFXa/0.4ml solution for injection ASPEN, nadroparin

General data about FRAXIPARINE 3800UI AFXa/0.4ml 3800 ui AFXa / 0.4ml

  • Substance: nadroparin
  • Date of latest medicines list: 01-02-2023
  • Product code: W61293001
  • Concentration: 3800 ui AFXa / 0.4ml
  • Pharmaceutical form: solution for injection
  • Quantity: 10
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ASPEN NOTRE DAME DE BONDEVILLE - FRANTA
  • Holder: ASPEN PHARMA TRADING LIMITED - IRLANDA
  • Number: 2519/2010/01
  • Shelf life: 3 years

Concentrations available for nadroparin

  • 11400 uiAFXa/0.6ml
  • 11400 uiAXa/0.6ml
  • 15200 uiAFXa/0.8ml
  • 15200 uiAXa/0.8ml
  • 19000 uiAFXa/1ml
  • 19000 uiAXa/ml
  • 2850 ui AFXa/0.3ml
  • 3800 ui AFXa/0.4ml
  • 5700 ui AFXa/0.6ml
  • 7600 ui AFXa/0.8ml
  • 7600 ui AXa/0.8ml
  • 9500 UI AFXa/1ml